Literature DB >> 17275386

VIRTOPSY - the Swiss virtual autopsy approach.

Michael J Thali1, Christian Jackowski, Lars Oesterhelweg, Steffen G Ross, Richard Dirnhofer.   

Abstract

The aim of the VIRTOPSY project () is utilizing radiological scanning to push low-tech documentation and autopsy procedures in a world of high-tech medicine in order to improve scientific value, to increase significance and quality in the forensic field. The term VIRTOPSY was created from the terms virtual and autopsy: Virtual is derived from the Latin word 'virtus', which means 'useful, efficient and good'. Autopsy is a combination of the old Greek terms 'autos' (=self) and 'opsomei' (=I will see). Thus autopsy means 'to see with ones own eyes'. Because our goal was to eliminate the subjectivity of "autos", we merged the two terms virtual and autopsy - deleting "autos" - to create VIRTOPSY. Today the project VIRTOPSY combining the research topics under one scientific umbrella, is characterized by a trans-disciplinary research approach that combines Forensic Medicine, Pathology, Radiology, Image Processing, Physics, and Biomechanics to an international scientific network. The paper will give an overview of the Virtopsy change process in forensic medicine.

Mesh:

Year:  2007        PMID: 17275386     DOI: 10.1016/j.legalmed.2006.11.011

Source DB:  PubMed          Journal:  Leg Med (Tokyo)        ISSN: 1344-6223            Impact factor:   1.376


  44 in total

1.  [Virtual autopsy (virtopsy) in forensic science: from the scalpel to the scanner].

Authors:  M Thali
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

2.  Common and expected postmortem CT observations involving the brain: mimics of antemortem pathology.

Authors:  A B Smith; G E Lattin; P Berran; H T Harcke
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-05       Impact factor: 3.825

3.  Development and validation of a postmortem radiological alteration index: the RA-Index.

Authors:  C Egger; P Vaucher; F Doenz; C Palmiere; P Mangin; S Grabherr
Journal:  Int J Legal Med       Date:  2012-03-09       Impact factor: 2.686

4.  Reconstruction and 3D visualisation based on objective real 3D based documentation.

Authors:  Michael J Bolliger; Ursula Buck; Michael J Thali; Stephan A Bolliger
Journal:  Forensic Sci Med Pathol       Date:  2011-10-07       Impact factor: 2.007

5.  Distribution of artifactual gas on post-mortem multidetector computed tomography (MDCT).

Authors:  Coraline Egger; Pierre Bize; Paul Vaucher; Pascal Mosimann; Benjamin Schneider; Alejandro Dominguez; Reto Meuli; Patrice Mangin; Silke Grabherr
Journal:  Int J Legal Med       Date:  2011-01-05       Impact factor: 2.686

6.  Demonstration of liver metastases on postmortem whole body CT angiography following inadvertent systemic venous infusion of the contrast medium.

Authors:  Chris O'Donnell; Jacqueline Hislop-Jambrich; Noel Woodford; Melissa Baker
Journal:  Int J Legal Med       Date:  2012-01-22       Impact factor: 2.686

7.  Image analysis of pubic bone for sex determination in a computed tomography sample.

Authors:  Manuel López-Alcaraz; Pedro Manuel Garamendi González; Inmaculada Alemán Aguilera; Miguel Botella López
Journal:  Int J Legal Med       Date:  2013-08-25       Impact factor: 2.686

8.  Virtopsy versus digital autopsy: virtual autopsy.

Authors:  C Pomara; V Fineschi; G Scalzo; G Guglielmi
Journal:  Radiol Med       Date:  2009-08-07       Impact factor: 3.469

9.  Whole-body post-mortem computed tomography compared with autopsy in the investigation of unexpected death in infants and children.

Authors:  Maïa Proisy; Antoine Jérôme Marchand; Philippe Loget; Renaud Bouvet; Michel Roussey; Fabienne Pelé; Céline Rozel; Catherine Treguier; Pierre Darnault; Bertrand Bruneau
Journal:  Eur Radiol       Date:  2012-12-16       Impact factor: 5.315

10.  A comparative study of cranial, blunt trauma fractures as seen at medicolegal autopsy and by computed tomography.

Authors:  Christina Jacobsen; Birthe H Bech; Niels Lynnerup
Journal:  BMC Med Imaging       Date:  2009-10-16       Impact factor: 1.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.